Regulus Therapeutics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGLS research report →
Companywww.regulusrx.com
Regulus Therapeutics Inc. , a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease.
- CEO
- Joseph P. Hagan
- IPO
- 2012
- Employees
- 34
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $564.95M
- P/E
- -24.08
- P/S
- 1661.62
- P/B
- 7.82
- EV/EBITDA
- -23.26
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -50.59%
- Op Margin
- -7142.35%
- Net Margin
- -6595.59%
- ROE
- -30.84%
- ROIC
- -34.48%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-46,358,000 · -54.34%
- EPS
- $-0.82 · 48.10%
- Op Income
- $-50,040,000
- FCF YoY
- -53.44%
Performance & Tape
- 52W High
- $8.35
- 52W Low
- $0.83
- 50D MA
- $7.14
- 200D MA
- $2.89
- Beta
- 0.37
- Avg Volume
- 2.16M
Get TickerSpark's AI analysis on RGLS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 25 | RASTETTER WILLIAM H | other | 44,264 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 30,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 15,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 60,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 2,325 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 9,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 4,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 57,292 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 4,650 |
| Jun 25, 25 | Witz Pascale | sell | 4,000 |
Our RGLS Coverage
We haven't published any research on RGLS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RGLS Report →